14/12/2025
Cannabis, the Endocannabinoid System, and Why Fiji Must Treat It as a Medical Issue — Not a Criminal One
In Fiji today, many people remain uncertain about what cannabis really is — and how it affects the human body.¹ For decades, cannabis has been treated primarily as a criminal matter under national drug laws.² But recent science and international developments now clearly tell a different story: around the world — including through the United Nations (UN) — cannabis is formally recognized as having legitimate medical value.³
This means cannabis is no longer just a law-and-order issue, but a public health and medical issue as well.³ This raises a clear question for Fiji: if the world now recognizes cannabis as medicine, why is Fiji still treating it mainly as a crime?
What Is the Endocannabinoid System (ECS)?
One of the key ways cannabis works is by interacting with a natural system that exists in every human: the Endocannabinoid System (ECS).⁴
Think of your body like a complex, finely tuned instrument. To stay healthy, the body needs many processes — sleep, mood, appetite, pain perception, immune responses — to stay in balance.⁵ The ECS is one of the body’s internal regulators that helps maintain that balance, a state known as homeostasis.⁴
The ECS operates through three main parts:
Endocannabinoids — molecules your body produces naturally; they act like “keys.”⁶
Receptors — “locks” located throughout the brain, nerves, organs and other tissues, where these keys bind.⁷
Enzymes — molecules that break down endocannabinoids when they’re no longer needed — the “cleanup crew.”⁴
When something disrupts your balance — like pain, stress, or illness — the ECS works to restore stability.⁸ Because the ECS influences many physiological processes (pain, mood, immunity, digestion, sleep), it plays a central role in overall health.⁴⁵
How Cannabis Interacts With the ECS
Cannabis contains plant-based cannabinoids — most notably THC and CBD — which are chemically different but functionally similar to the body’s own endocannabinoids.⁴⁷
When a person uses cannabis, these cannabinoids can bind to ECS receptors — much like extra keys — influencing how the body responds.⁷
THC can produce effects that may include relief from pain, reduction of nausea, appetite stimulation, and relaxation.⁹
CBD does not produce the “high” associated with THC.¹⁰ It has been clinically researched for certain forms of epilepsy and may also have anti-inflammatory and calming effects.¹¹
Because of these effects, many people worldwide now use cannabis-based medicines for chronic pain, epilepsy, chemotherapy side-effects, sleep difficulties, and more.⁹¹¹
In December 2020, after a scientific review by the World Health Organization (WHO), the United Nations officially removed cannabis from its most dangerous drug category (Schedule IV) and formally recognized its medical value.³
Why This Matters for Fiji
Under current laws in Fiji — the Illicit Drugs Control Act 2004 — most forms of cannabis remain illegal.²
In 2022, Fiji passed an amendment that created a legal distinction between industrial h**p (cannabis with -1% THC) and other forms of cannabis, allowing h**p farming and export under strict regulation.¹²
However, medical cannabis remains illegal, and all other cannabis is still treated as a criminal substance under the same Act.²¹²
This means many people in Fiji suffering from:
• Chronic pain
• Epilepsy
• Cancer-related symptoms
• Sleep disorders and
• inflammation
— conditions for which cannabis shows real medical promise — still lack lawful access to treatment and risk criminal punishment simply for trying to manage their health.⁹¹¹
Right now, Fiji’s laws are treating a substance the United Nations recognizes as medicine as if it were only a criminal threat.³²
What Reform Could Offer — With Care and Nuance
Given the science and the UN’s medical recognition, reforming Fiji’s approach could offer several benefits:
Medical access for patients in need
Economic opportunities — under the 2022 amendment, Fiji already opened the door to h**p cultivation and export¹²
A regulatory path that separates industrial h**p, medical cannabis, and illicit recreational use while ensuring safety, quality, and controlled distribution¹³
If done responsibly — with medical oversight, licensing, dosage standards, and public education — cannabis-based therapies will support Fiji’s health system instead of burdening the justice system.¹³
Key Realities & Necessary Nuances
Not all medical claims about cannabis are equally supported. Evidence is stronger for some conditions (such as epilepsy and chemotherapy-related nausea) than for others (such as chronic pain, anxiety, or sleep).⁹¹¹
Legal reform must include:
• Medical regulation
• Quality control
• THC limits
• Doctor-guided access
The fact that Fiji legalized h**p shows political willingness to engage with cannabis regulation — but h**p legalization is not the same as medical legalization.¹²
Conclusion: A Health-First, Evidence-Driven Approach
The Endocannabinoid System and global medical research show clearly that cannabis is not just a “street drug.”⁴⁹ It interacts with a real biological system, and under controlled medical conditions, can offer real therapeutic benefit.⁹¹¹
For Fiji, the choice is now clear: continue treating cannabis only as a criminal issue, or accept the UN’s recognition and move toward a health-first, science-based policy.³²
Once the world’s highest drug authority recognizes cannabis as medicine, continuing to treat patients as criminals becomes a failure of medical justice — not just a policy debate.³
It is time for Fiji’s cannabis policy to catch up with science and global medical standards.
Vinaka.
Footnotes / References
1. Regional media & public health commentary on cannabis education gaps in the Pacific
2. Fiji — Illicit Drugs Control Act 2004
3. United Nations Commission on Narcotic Drugs (CND), Dec 2020 rescheduling vote following WHO review
4. Lu & Mackie, Endocannabinoid System Review, PubMed Central
5. General physiology & homeostasis (standard medical science)
6. Anandamide & 2-AG (primary human endocannabinoids)
7. CB1 & CB2 receptor distribution studies
8. ECS stress-response & immune modulation research
9. National Academies of Sciences (2017) — cannabis for pain, nausea, appetite
10. WHO CBD Review Report (2018)
11. FDA approval of Epidiolex (CBD) for epilepsy
12. Fiji — Illicit Drugs Control (Budget Amendment) Act 2022
13. WHO / Health Canada / Australian TGA medical cannabis regulatory frameworks
Sign the Petition for Cannabis Reform in Fiji: www.change.org/p/decriminalize-cannabis-in-fiji-for-our-health-wealth-and-justice ***aFiji